Actively Recruiting
A Prospective Study of Factors Related to Exacerbation and Mortality of Non-cystic Fibrosis Bronchiectasis in Hong Kong
Led by Chinese University of Hong Kong · Updated on 2020-09-04
400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Bronchiectasis is a lung condition marked by repeated flare-ups, occurring 1.5 to 6.5 times per patient each year. These flare-ups increase the risk of hospital admissions and lead to high healthcare costs. A previous local study found that most patients with bronchiectasis, primarily females, had idiopathic disease with significant hospitalizations and mortality rates. This research aims to update the understanding of bronchiectasis prevalence, causes, symptoms, and outcomes to improve future management plans. This observational study follows adults diagnosed with bronchiectasis confirmed by a high-resolution CT scan. Participants must be clinically stable for at least four weeks before joining and will be monitored over five years without any interventional treatment. The study will record the number of bronchiectasis flare-ups and mortality rates during this period to better understand disease progression. Participants will be observed for five years, during which their frequency of exacerbations and survival will be tracked. The study will collect data on symptom changes, hospitalizations, and treatment needs. This long-term follow-up aims to provide comprehensive information to guide care strategies and reduce the impact of bronchiectasis on patients' health and healthcare resources.
CONDITIONS
Brief Title
A Prospective Study of Factors Related to Exacerbation and Mortality of Non-cystic Fibrosis Bronchiectasis in Hong Kong
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Clinically stable for at least 4 weeks prior to enrollment with no symptoms of exacerbation or need for antibiotic therapy
- Diagnosis of bronchiectasis confirmed by high-resolution computed tomography scan
You will not qualify if you...
- History of cystic fibrosis, hypogammaglobulinemia, or allergic bronchopulmonary aspergilosis
- Unable to give consent to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 5 years
Participants are observed to track bronchiectasis exacerbations and mortality over time.
Trial Site Locations
Total: 1 location
1
Chinese University of Hong
Hong Kong, Please Select, Hong Kong
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here